logo
Plus   Neg
Share
Email

Genentech : Late-stage Study Shows Xofluza Prevents Influenza Infection

Genentech, a member of the Roche Group (RHHBY), said Tuesday that Phase III study, dubbed BLOCKSTONE, showed Xofluza was effective at preventing influenza infection.

The company noted that the late-stage Blockstone study, conducted by Shionogi & Co., met its primary endpoint showing that people exposed to a household member with influenza and treated preventatively with Xofluza were significantly less likely to develop the disease compared to those treated with placebo. In addition, Xofluza was well tolerated with no safety signals identified.

Xofluza is currently approved in Japan for the treatment of influenza types A and B in children, adolescents and adults, and in the U.S. for the treatment of acute, uncomplicated influenza in people 12 years of age and older.

Recently, the U.S. Food and Drug Administration accepted a supplemental New Drug Application for Xofluza as a one-dose oral treatment for people at high risk of complications from the flu, which includes adults 65 years of age or older, or those who have conditions such as asthma, chronic lung disease, morbid obesity or heart disease - for these people the flu can be particularly serious or deadly.

It is expected that the FDA will decide on whether to approve the additional indication by November 4, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Libra Association, formed by major financial partners of Facebook's Libra cryptocurrency project, formalized the association at the inaugural Libra Council meeting of the members at its headquarters in Geneva, Switzerland. The current 21 member organizations formally signed onto the Libra Association charter, elected the Board of Directors, and appointed the executive team. Department store chain Kohl's Corp. has unveiled its Kohl's Cares holiday collection that includes the Disney Frozen 2 and Holiday Character bundles. The company's philanthropic program, Kohl's Cares, sells children's books as well as toys and donates the entire profit to charitable initiatives nationwide. Children's Place Inc. (PLCE) said that it will relaunch the Gymboree brand in the U.S. and Canada in early 2020. The brand will be relaunched in Gymboree website, and in shop-in-shop locations in more than 200 Children's Place stores in the U.S. and Canada.
Follow RTT
>